Journal of mucopolysaccharidosis and rare diseases

Association for Research of MPS and Rare Diseases (뮤코다당증연구학회)
권호 표지
DOI QR코드

DOI QR Code

The Effect of Growth Hormone on mRNA Expression of the GABAB1 Receptor Subunit and GH/IGF Axis Genes in a Mouse Model of Prader-Willi Syndrome

  • Lee, Jin Young (Department of Health Science and Technology, Graduate School, SAIHST, Sungkyunkwan University) ;
  • Jin, Dong-Kyu (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • Received : 2015.10.21
  • Accepted : 2015.11.20
  • Published : 2015.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Growth hormone (GH) therapy substantially improves several cognitive functions in PWS. However, the molecular mechanisms underlying the beneficial effects of GH on cognition remain unclear in PWS. In this study, we investigated the effects of recombinant human GH on the gene expression of GABAB receptor subunits and GH/insulin-like growth factor (IGF) axis genes in the brain regions of PWS-mimicking mice (Snord116del). Methods: Snord116del mice were injected subcutaneously with 1.0 mg/kg GH or saline, once daily for 7 days. The collected brain tissues were analyzed for mRNA content using quantitative PCR (qPCR) in the cerebellum, hippocampus, and cerebral cortex. Results: GH increased the mRNA expression level of the $GABA_{B1}$ receptor subunit ($GABA_{BR1}$) and IGF-1R in the cerebellum. Furthermore, a significant positive correlation was found between the level of $GABA_{BR1}$ mRNA and the expression of the IGF-1R transcript. GH also induced an increase in the mRNA expression of IGF-2 and IGF-2R in the cerebellum. Conclusion: These data indicate that GH may provide beneficial effects on cognitive function through its influences on the expression of $GABA_{BR1}$ and GH/IGF-1 axis genes in PWS patients.

Keywords

References

  1. Cassidy SB. Prader-Willi syndrome. J Med Genet (5.703) 1997;34:917-23. https://doi.org/10.1136/jmg.34.11.917
  2. Swaab DF, Purba JS, Hofman MA. Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases. J Clin Endocrinol Metab 1995;80:573-9.
  3. Festen DA, Wevers M, Lindgren AC, Böhm B, Otten BJ, Wit JM, et al. Mental and motor development before and during growth hormone treatment in infants and toddlers with Prader-Willi syndrome. Clin Endocrinol (Oxf) 2008;68:919-25. https://doi.org/10.1111/j.1365-2265.2007.03126.x
  4. Myers SE, Whitman BY, Carrel AL, Moerchen V, Bekx MT, Allen DB. Two years of growth hormone therapy in young children with Prader-Willi syndrome: physical and neurodevelopmental benefits. Am J Med Genet A 2007;143A:443-8. https://doi.org/10.1002/ajmg.a.31468
  5. Hoybye C, Thoren M, Bohm B. Cognitive, emotional, physical and social effects of growth hormone treatment in adults with Prader-Willi syndrome. J Intellect Disabil Res 2005;49:245-52. https://doi.org/10.1111/j.1365-2788.2005.00641.x
  6. Siemensma EP, Tummers-de Lind van Wijngaarden RF, Festen DA, Troeman ZC, van Alfen-van der Velden AA, Otten BJ, et al. Beneficial effects of growth hormone treatment on cognition in children with Prader-Willi syndrome: a randomized controlled trial and longitudinal study. J Clin Endocrinol Metab 2012;97:2307-14. https://doi.org/10.1210/jc.2012-1182
  7. Sonntag WE, Ramsey M, Carter CS. Growth hormone and insulin-like growth factor-1 (IGF-1) and their influence on cognitive aging. Ageing Res Rev 2005;4:195-212. https://doi.org/10.1016/j.arr.2005.02.001
  8. Nyberg F, Hallberg M. Growth hormone and cognitive function. Nat Rev Endocrinol 2013;9:357-65. https://doi.org/10.1038/nrendo.2013.78
  9. Le Greves M, Zhou Q, Berg M, Le Grevès P, Fhölenhag K, Meyerson B, et al. Growth hormone replacement in hypophysectomized rats affects spatial performance and hippocampal levels of NMDA receptor subunit and PSD-95 gene transcript levels. Exp Brain Res 2006;173:267-73. https://doi.org/10.1007/s00221-006-0438-2
  10. Chen DY, Stern SA, Garcia-Osta A, Saunier-Rebori B, Pollonini G, Bambah-Mukku D, et al. A critical role for IGFII in memory consolidation and enhancement. Nature 2011;469:491-7. https://doi.org/10.1038/nature09667
  11. Nyberg F, Burman P. Growth hormone and its receptors in the central nervous system--location and functional significance. Horm Res 1996;45:18-22.
  12. Pan W, Yu Y, Cain CM, Nyberg F, Couraud PO, Kastin AJ. Permeation of growth hormone across the blood-brain barrier. Endocrinology 2005;146:4898-904. https://doi.org/10.1210/en.2005-0587
  13. Jones KA, Borowsky B, Tamm JA, Craig DA, Durkin MM, Dai M, et al. GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. Nature 1998;396:674-9. https://doi.org/10.1038/25348
  14. Goudet C, Magnaghi V, Landry M, Nagy F, Gereau RWt, Pin JP. Metabotropic receptors for glutamate and GABA in pain. Brain Res Rev 2009;60:43-56. https://doi.org/10.1016/j.brainresrev.2008.12.007
  15. Benarroch EE. GABAB receptors: structure, functions, and clinical implications. Neurology 2012;78:578-84. https://doi.org/10.1212/WNL.0b013e318247cd03
  16. Gronbladh A, Johansson J, Nyberg F, Hallberg M. Recombinant human growth hormone affects the density and functionality of GABAB receptors in the male rat brain. Neuroendocrinology 2013;97:203-11. https://doi.org/10.1159/000339821
  17. Walser M, Hansen A, Svensson PA, Jernas M, Oscarsson J, Isgaard J, et al. Peripheral administration of bovine GH regulates the expression of cerebrocortical beta-globin, GABAB receptor 1, and the Lissencephaly-1 protein (LIS-1) in adult hypophysectomized rats. Growth Horm IGF Res 2011;21:16-24. https://doi.org/10.1016/j.ghir.2010.11.002
  18. Aberg ND, Carlsson B, Rosengren L, Oscarsson J, Isaksson OG, Ronnback L, et al. Growth hormone increases connexin- 43 expression in the cerebral cortex and hypothalamus. Endocrinology 2000;141:3879-86. https://doi.org/10.1210/endo.141.10.7731
  19. Aramburo C, Alba-Betancourt C, Luna M, Harvey S. Expression and function of growth hormone in the nervous system: a brief review. Gen Comp Endocrinol 2014;203:35-42. https://doi.org/10.1016/j.ygcen.2014.04.035
  20. Davies CH, Starkey SJ, Pozza MF, Collingridge GL. GABA autoreceptors regulate the induction of LTP. Nature 1991; 349:609-11. https://doi.org/10.1038/349609a0
  21. Gronbladh A, Johansson J, Nyberg F, Hallberg M. Administration of growth hormone and nandrolone decanoate alters mRNA expression of the GABA receptor subunits as well as of the GH receptor, IGF-1, and IGF-2 in rat brain. Growth Horm IGF Res 2014;24:60-6. https://doi.org/10.1016/j.ghir.2014.01.002
  22. Tu H, Xu C, Zhang W, Liu Q, Rondard P, Pin JP, et al. GABAB receptor activation protects neurons from apoptosis via IGF-1 receptor transactivation. J Neurosci 2010;30:749-59. https://doi.org/10.1523/JNEUROSCI.2343-09.2010
  23. Zhang F, Li C, Wang R, Han D, Zhang QG, Zhou C, et al. Activation of GABA receptors attenuates neuronal apoptosis through inhibiting the tyrosine phosphorylation of NR2A by Src after cerebral ischemia and reperfusion. Neuroscience 2007;150:938-49. https://doi.org/10.1016/j.neuroscience.2007.09.070
  24. Xu J, Li C, Yin XH, Zhang GY. Additive neuroprotection of GABA A and GABA B receptor agonists in cerebral ischemic injury via PI-3K/Akt pathway inhibiting the ASK1- JNK cascade. Neuropharmacology 2008;54:1029-40. https://doi.org/10.1016/j.neuropharm.2008.01.014
  25. Li CJ, Lu Y, Zhou M, et al. Activation of GABAB receptors ameliorates cognitive impairment via restoring the balance of HCN1/HCN2 surface expression in the hippocampal CA1 area in rats with chronic cerebral hypoperfusion. Mol Neurobiol 2014;50:704-20. https://doi.org/10.1007/s12035-014-8736-3
  26. Russo VC, Gluckman PD, Feldman EL, Werther GA. The insulin-like growth factor system and its pleiotropic functions in brain. Endocr Rev 2005;26:916-43. https://doi.org/10.1210/er.2004-0024
  27. Rotwein P, Burgess SK, Milbrandt JD, Krause JE. Differential expression of insulin-like growth factor genes in rat central nervous system. Proc Natl Acad Sci U S A 1988;85:265-9. https://doi.org/10.1073/pnas.85.1.265
  28. Alba-Betancourt C, Aramburo C, Avila-Mendoza J, Ahumada- Solórzano SM, Carranza M, Rodriguez-Mendez AJ, et al. Expression, cellular distribution, and heterogeneity of growth hormone in the chicken cerebellum during development. Gen Comp Endocrinol 2011;170:528-40. https://doi.org/10.1016/j.ygcen.2010.11.009
  29. Carson MJ, Behringer RR, Brinster RL, McMorris FA. Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice. Neuron 1993;10:729-40. https://doi.org/10.1016/0896-6273(93)90173-O
  30. Alba-Betancourt C, Luna-Acosta JL, Ramirez-Martinez CE, Avila-Gonzalez D, Granados-Avalos E, Carranza M, et al. Neuro-protective effects of growth hormone (GH) after hypoxia-ischemia injury in embryonic chicken cerebellum. Gen Comp Endocrinol 2013;183:17-31. https://doi.org/10.1016/j.ygcen.2012.12.004
  31. Noguchi T, Sugiasaki T, Tsukada Y. Microcephalic cerebrum with hypomyelination in the growth hormone-deficient mouse (lit). Neurochem Res 1985;10:1097-106. https://doi.org/10.1007/BF00965884